AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 170 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 1.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $391,669 | -10.9% | 15,825 | +1.9% | 0.00% | -25.0% |
| Q2 2023 | $439,781 | +33.6% | 15,529 | +8.4% | 0.00% | +33.3% |
| Q1 2023 | $329,114 | -15.8% | 14,328 | +2.9% | 0.00% | -25.0% |
| Q4 2022 | $390,902 | +3.1% | 13,921 | +3.9% | 0.00% | 0.0% |
| Q3 2022 | $379,000 | +28.5% | 13,400 | +0.6% | 0.00% | +33.3% |
| Q2 2022 | $295,000 | -23.4% | 13,326 | +0.9% | 0.00% | 0.0% |
| Q1 2022 | $385,000 | -17.9% | 13,212 | -7.5% | 0.00% | -25.0% |
| Q4 2021 | $469,000 | -32.7% | 14,280 | -5.4% | 0.00% | -33.3% |
| Q3 2021 | $697,000 | -25.7% | 15,095 | -11.4% | 0.01% | -25.0% |
| Q2 2021 | $938,000 | +0.1% | 17,028 | -6.2% | 0.01% | 0.0% |
| Q1 2021 | $937,000 | +19.8% | 18,145 | +0.6% | 0.01% | +14.3% |
| Q4 2020 | $782,000 | +19.4% | 18,038 | -3.6% | 0.01% | 0.0% |
| Q3 2020 | $655,000 | -12.0% | 18,708 | +34.4% | 0.01% | -30.0% |
| Q2 2020 | $744,000 | +48.2% | 13,918 | -1.7% | 0.01% | +11.1% |
| Q1 2020 | $502,000 | – | 14,157 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 965,369 | $56,378,000 | 14.98% |
| Casdin Capital, LLC | 237,500 | $13,870,000 | 8.18% |
| BB BIOTECH AG | 2,839,528 | $165,828,000 | 5.42% |
| Opaleye Management Inc. | 130,000 | $7,592,000 | 3.78% |
| Redmile Group, LLC | 902,578 | $52,711,000 | 3.42% |
| Clarius Group, LLC | 109,230 | $6,379,000 | 2.63% |
| Opus Point Partners Management, LLC | 57,410 | $3,353,000 | 2.49% |
| Ghost Tree Capital, LLC | 125,000 | $7,300,000 | 1.36% |
| CAPITAL INTERNATIONAL LTD /CA/ | 346,937 | $20,261,000 | 1.32% |
| Eventide Asset Management | 300,800 | $17,567,000 | 1.16% |